These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 9799061)

  • 1. Synthesis of pharmacokinetic parameters of vancomycin via bootstrap methods.
    Zellner D; Frankewitsch T; Keller F
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):554-60. PubMed ID: 9799061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical analysis of heterogeneous pharmacokinetic data from the literature.
    Zellner D; Frankewitsch T; Simon S; Keller F
    Eur J Clin Chem Clin Biochem; 1996 Jul; 34(7):585-9. PubMed ID: 8864411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dependence of vancomycin clearance on renal function via regression and bootstrap methods.
    Zellner D; Zellner GE; Keller F
    J Clin Pharm Ther; 1998 Apr; 23(2):107-13. PubMed ID: 9786096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of various estimates of renal function on prediction of vancomycin concentration by the population mean and Bayesian methods.
    Tsuji Y; Hiraki Y; Mizoguchi A; Sadoh S; Sonemoto E; Kamimura H; Karube Y
    J Clin Pharm Ther; 2009 Aug; 34(4):465-72. PubMed ID: 19583680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance of vancomycin during high-efficiency hemodialysis.
    Klansuwan N; Ratanajamit C; Kasiwong S; Wangsiripaisan A
    J Med Assoc Thai; 2006 Jul; 89(7):986-91. PubMed ID: 16881431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
    Yang RH; Rong XZ; Hua R; Zhang T
    Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
    Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
    J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of bootstrap methods for estimating sample size and analysing health-related quality of life outcomes.
    Walters SJ; Campbell MJ
    Stat Med; 2005 Apr; 24(7):1075-102. PubMed ID: 15570625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the bootstrap in analysing cost data from cluster randomised trials: some simulation results.
    Flynn TN; Peters TJ
    BMC Health Serv Res; 2004 Nov; 4(1):33. PubMed ID: 15550169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetic analysis of vancomycin in patients with gram-positive infections and the influence of infectious disease type.
    Yamamoto M; Kuzuya T; Baba H; Yamada K; Nabeshima T
    J Clin Pharm Ther; 2009 Aug; 34(4):473-83. PubMed ID: 19583681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-parametric estimators of a monotonic dose-response curve and bootstrap confidence intervals.
    Dilleen M; Heimann G; Hirsch I
    Stat Med; 2003 Mar; 22(6):869-82. PubMed ID: 12627406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of glomerular filtration rate on the clearance of vancomycin administered by continuous infusion in burn patients.
    Dailly E; Le Floch R; Deslandes G; Pannier M; Jolliet P
    Int J Antimicrob Agents; 2008 Jun; 31(6):537-9. PubMed ID: 18462925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient estimation of log-normal means with application to pharmacokinetic data.
    Shen H; Brown LD; Zhi H
    Stat Med; 2006 Sep; 25(17):3023-38. PubMed ID: 16345103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.
    Bolon-Larger M; Chamouard V; Bressolle F; Boulieu R
    Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function.
    Tanaka A; Suemaru K; Otsuka T; Ido K; Nishimiya T; Sakai I; Hasegawa H; Inoue T; Murase M; Yasukawa M; Araki H
    Ther Drug Monit; 2007 Apr; 29(2):261-4. PubMed ID: 17417082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of several methods for analyzing censored data.
    Hewett P; Ganser GH
    Ann Occup Hyg; 2007 Oct; 51(7):611-32. PubMed ID: 17940277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.
    DelDot ME; Lipman J; Tett SE
    Br J Clin Pharmacol; 2004 Sep; 58(3):259-68. PubMed ID: 15327585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian estimation of pharmacokinetic parameters of vancomycin in patients with decreasing renal function.
    Yamamoto T; Terakawa H; Hisaka A; Suzuki H
    J Pharm Sci; 2012 Aug; 101(8):2968-75. PubMed ID: 22570265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma.
    Niioka T; Uno T; Yasui-Furukori N; Takahata T; Shimizu M; Sugawara K; Tateishi T
    Cancer Chemother Pharmacol; 2007 Apr; 59(5):575-80. PubMed ID: 16912889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.